Search results
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
CBS 47 Fresno· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas | JD Supra
JD Supra· 5 days agoIf you have been diagnosed with acute myeloid leukemia but cannot figure out why, benzene may be responsible. Benzene, a chemical used in various industries ...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 hours agoToday, we are providing updates for our highly differentiated LSD1 inhibitor the XS74539, or 539, which continues its progression towards a Phase 1 clinical trial in acute myeloid< ...
MD Anderson Research Highlights for May 21, 2024 | Newswise
Newswise· 1 day agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoPRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with
What Is Immunophenotyping?
Healthline· 7 days agoImmunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 7 days agoAlthough as it still has no drugs approved by the Food and Drug Administration, incremental updates...
Q2 2024 EPS Estimates for Tenax Therapeutics, Inc. Reduced by Analyst (NASDAQ:TENX)
ETF DAILY NEWS· 5 days agoTenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at Roth Capital dropped their Q2 2024 earnings per share estimates for shares of Tenax Therapeutics in a research ...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 7 days agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Rishi Gupta Sells 1,033,300 Shares of Stock
ETF DAILY NEWS· 1 day agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rishi Gupta sold 1,033,300 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were ...
